Indo US Bio-Tech standalone net profit declines 40.59% in the December 2025 quarter
Sales decline 3.23% to Rs 22.80 crore
Net profit of Indo US Bio-Tech declined 40.59% to Rs 3.00 crore in the quarter ended December 2025 as against Rs 5.05 crore during the previous quarter ended December 2024. Sales declined 3.23% to Rs 22.80 crore in the quarter ended December 2025 as against Rs 23.56 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales22.8023.56 -3 OPM %18.2023.47 -PBDT3.395.17 -34 PBT3.175.01 -37 NP3.005.05 -41Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 21 2026 | 4:51 PM IST